Moderated Poster Research Articles

Club 35 Moderated Poster session: Wednesday 3 December 2014, 09:00-16:00 * Location: Moderated Poster area

Club 35 Moderated Poster session: Wednesday 3 December 2014, 09:00-16:00 * Location: Moderated Poster area

MODERATED POSTER SESSION: New imaging techniques in classical scenarios: Saturday 6 December 2014, 08:30-12:30 * Location: Moderated Poster area

MODERATED POSTER SESSION: New imaging techniques in classical scenarios: Saturday 6 December 2014, 08:30-12:30 * Location: Moderated Poster area

MODERATED POSTER SESSION: Imaging in interventional cardiology: Wednesday 3 December 2014, 09:00-16:00 * Location: Moderated Poster area

MODERATED POSTER SESSION: Imaging in interventional cardiology: Wednesday 3 December 2014, 09:00-16:00 * Location: Moderated Poster area

MODERATED POSTER SESSION: Imaging in cardiomyopathies: Friday 5 December 2014, 08:30-18:00 * Location: Moderated Poster area

MODERATED POSTER SESSION: Imaging in cardiomyopathies: Friday 5 December 2014, 08:30-18:00 * Location: Moderated Poster area

MODERATED POSTER SESSION: Don't look only at the left ventricule: Wednesday 3 December 2014, 09:00-16:00 * Location: Moderated Poster area

MODERATED POSTER SESSION: Don't look only at the left ventricule: Wednesday 3 December 2014, 09:00-16:00 * Location: Moderated Poster area

MODERATED POSTER SESSION: Athletes heart systemic diseases, pulmonary heart disease, miscelaneous disease: Thursday 4 December 2014, 08:30-18:00 * Location: Moderated Poster area

MODERATED POSTER SESSION: Athletes heart systemic diseases, pulmonary heart disease, miscelaneous disease: Thursday 4 December 2014, 08:30-18:00 * Location: Moderated Poster area

P-119 * DIFFERENT MEASURES TO PREVENT ATRIAL FIBRILLATION IN PATIENTS UNDERGOING PULMONARY RESECTION FOR LUNG CANCER: EVIDENCE FROM A COMPREHENSIVE NETWORK META-ANALYSIS OF RANDOMIZED AND OBSERVATIONAL STUDIES

s 22nd European Conference on General Thoracic Surgery June 15-18, 2014, Copenhagen, Denmark SESSION VII: Moderated Posters MONDAY, 16 JUNE 2014 17:30 19:00

Moderated Posters session * New insights into risk stratification in valvular heart disease - Part B: 11/12/2013, 09:30-16:00 * Location: Moderated Poster area

Moderated Posters session * New insights into risk stratification in valvular heart disease - Part B: 11/12/2013, 09:30-16:00 * Location: Moderated Poster area

Moderated Posters session * Cardiovascular computed tomography, magnetic resonance and nuclear imaging: 13/12/2013, 08:30-12:30 * Location: Moderated Poster area

Moderated Posters session * Cardiovascular computed tomography, magnetic resonance and nuclear imaging: 13/12/2013, 08:30-12:30 * Location: Moderated Poster area

Moderated Posters session * The prognostic value of myocardial deformation imaging in cardiomyopathy: 12/12/2013, 08:30-12:30 * Location: Moderated Poster area

Moderated Posters session * The prognostic value of myocardial deformation imaging in cardiomyopathy: 12/12/2013, 08:30-12:30 * Location: Moderated Poster area

Moderated Posters session * Insights into the use of contrast stress echocardiography and 3D strain: 14/12/2013, 08:30-12:30 * Location: Moderated Poster area

Moderated Posters session * Insights into the use of contrast stress echocardiography and 3D strain: 14/12/2013, 08:30-12:30 * Location: Moderated Poster area

Moderated Posters session * New insights into risk stratification in valvular heart disease - Part A: 11/12/2013, 09:30-16:00 * Location: Moderated Poster area

Moderated Posters session * New insights into risk stratification in valvular heart disease - Part A: 11/12/2013, 09:30-16:00 * Location: Moderated Poster area

Moderated Poster

Cardiovascular TherapeuticsVolume 30, Issue s1 p. 39-63 Moderated PostersFree Access Moderated Poster First published: 29 November 2012 https://doi.org/10.1111/1755-5922.12011_2Citations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume30, Issues1Special Issue: Abstracts of the 3rd World Heart Failure Congress, 29 November – 02 December 2012, Harbiye Military Museum, Istanbul, TurkeyNovember 2012Pages 39-63 RelatedInformation

Moderated Posters Session 5

European Journal of Heart Failure SupplementsVolume 11, Issue S1 p. S237-S238 Tuesday 22 May 2012, 10:00–11:00, Location: Moderated Poster AreaFree Access Moderated Posters — Session 5 First published: 17 May 2012 https://doi.org/10.1093/eurjhf/hss016AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume11, IssueS1May 2012Pages S237-S238 RelatedInformation

Moderated Poster Session 1

European Journal of Heart Failure SupplementsVolume 11, Issue S1 p. S13-S14 Sunday 20 May 2012, 10:00–11:00, Location: Moderated Poster AreaFree Access Moderated Posters — Session 1 Cardiac Resynchronisation Therapy First published: 17 May 2012 https://doi.org/10.1093/eurjhf/hss005AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume11, IssueS1May 2012Pages S13-S14 RelatedInformation

Moderated Poster Session 2

European Journal of Heart Failure SupplementsVolume 11, Issue S1 p. S65-S66 Sunday 20 May 2012, 15:45–16:30, Location: Moderated Poster AreaFree Access Moderated Posters — Session 2 First published: 17 May 2012 https://doi.org/10.1093/eurjhf/hss007AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume11, IssueS1May 2012Pages S65-S66 RelatedInformation

A report from the 27th Annual Congress of the European Association of Urology (February 24-28, 2012 - Paris, France)

Aging populations worldwide are already increasing the frequency of diseases of the urinary tract, including not just malignancies such as prostate and bladder cancer, but also common diseases of the aging male, such as benign prostatic hyperplasia, as well as age-facilitated diseases of women, such as urinary incontinence. Upon this background, the European Association of Urology (EAU) 2012 congress opened the gates in Paris, with attendees from across Europe and beyond crowding the Palais des Congres, as well as the subway lines leading to it. Four hectic days of oral and moderated poster sessions began, where leading scientists and researchers presented and discussed the results of clinical and preclinical research into many areas of urology related with the treatment and management of patients. The following report reviews many of these findings presented during the meeting, with a most direct impact on the current and future treatment for urological diseases.

Moderated Poster Session

Annals of NeurologyVolume 72, Issue S16 p. S179-S181 137th Annual Meeting Moderated Poster Session First published: 28 December 2012 https://doi.org/10.1002/ana.23706AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume72, IssueS16Supplement: 137th Annual Meeting of the American Neurological Association2012Pages S179-S181 RelatedInformation

Moderated Poster Sessions 1: Valvular heart disease: from bench to bedside * Thursday 8 December 2011, 08:30-12:30 * Location: Moderated Poster Area

Moderated Poster Sessions 1: Valvular heart disease: from bench to bedside * Thursday 8 December 2011, 08:30-12:30 * Location: Moderated Poster Area

Moderated Poster Sessions 5: Cardiovascular remodeling: from bench to bedside * Saturday 10 December 2011, 08:30-12:30 * Location: Moderated Poster Area

P926 Cardiac involvement in systemic sclerosis: the added value of magnetic resonance imaging. L. Gargani1; A. Pingitore1; D. De Marchi2; S. Guiducci3; M. Doveri4; ML. Bazzichi4; M. Matucci-Cerenic3; S. Bombardieri4; M. Lombardi2; E. Picano1 CNR, Institute of Clinical Physiology, Pisa, Italy; Gabriele Monasterio Foundation-CNR Region Toscana, MRI Laboratory, Pisa, Italy; University of Florence, Department of Medicine, Division of Rheumatology, Florence, Italy; University of Pisa, Department of Internal Medicine, Rheumatology & Immunoallergology Units, Pisa, Italy